Farmaè S.p.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 116.31 million compared to EUR 82.48 million a year ago. Net loss was EUR 0.907556 million compared to EUR 0.08971 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 EUR | 0.00% | +4.07% | -35.70% |
May. 17 | Milan timidly bullish; Saipem advances | AN |
May. 07 | Talea Group launches its private label branded Farmaè | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.70% | 41.78M | |
+14.23% | 215B | |
-0.08% | 203B | |
+50.92% | 99.28B | |
-24.87% | 75.43B | |
+11.22% | 52.4B | |
+18.07% | 26.07B | |
+31.61% | 10.98B | |
-2.48% | 9.39B | |
-26.50% | 4.86B |
- Stock Market
- Equities
- FAR Stock
- News Talea Group S.p.A.
- Farmaè S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022